logo BDSP

Base documentaire


Votre avis nous intéresse

Le réseau BDSP met en oeuvre un projet d'innovation et d'amélioration de ses services, dans le souci constant de proposer des contenus de qualité adaptés aux besoins des utilisateurs.

Identifier de nouvelles sources de financements est la condition nécessaire pour assurer la poursuite et la pérennité de cet outil unique qu'est la BDSP, tout en le faisant évoluer.

Pour définir un nouveau modèle économique, nous avons besoin de votre avis : merci de répondre à notre enquête (temps estimé : 5 minutes).

Participer maintenant
Participer plus tard J'ai déjà participé

  1. Bone metabolism in patients with systemic lupus erythematosus : Effect of disease activity and glucocorticoid treatment.

    Article - En anglais

    The bone metabolism in patients with systemic lupus erythematosus (SLE) has previously been examined, but the results are conflicting.

    In the present study the bone mineral density (BMD) of the axial and the appendicular skeleton was examined by means of dual energy x-ray absorptiometry.

    The bone turnover was evaluated by means of biochemical markers in serum and urine in a prospective cohort consisting of 36 female and male SLE patients.

    Repeated measurements of BMD were performed for up to two years.

    The BMD was decreased in the hand and in the femoral neck but normal in the spine and in the distal forearm.

    A weak correlation was found between the BMD of the femoral neck and the total consumption of glucocorticoids.

    Apart from this finding the BMD was uninfluenced by treatment with glucocorticoids and cyclophosphamide.

    No significant changes of BMD were found during the follow-up period.

    The serum concentration of the carboxyterminal crosslinked telopeptide of type I collagen was increased in almost all patients, but no other biochemical markers of bone metabolism were abnormal.

    Mots-clés Pascal : Lupus érythémateux, Disséminé, Evolutivité, Traitement, Glucocorticoïde, Chimiothérapie, Ostéoporose, Exploration, Remodelage osseux, Spectrométrie absorption RX, Densité, Os, Epidémiologie, Analyse biochimique, Homme, Peau pathologie, Tissu conjonctif pathologie, Maladie système, Maladie autoimmune, Immunopathologie, Système ostéoarticulaire pathologie, Ostéopathie, Exploration radiologique, Double énergie

    Mots-clés Pascal anglais : Lupus erythematosus, Disseminated, Evolutivity, Treatment, Glucocorticoid, Chemotherapy, Osteoporosis, Exploration, Bone remodeling, X ray absorption spectrometry, Density, Bone, Epidemiology, Biochemical analysis, Human, Skin disease, Connective tissue disease, Systemic disease, Autoimmune disease, Immunopathology, Diseases of the osteoarticular system, Bone disease, Radiologic investigation, Dual energy

    Logo du centre Notice produite par :
    Inist-CNRS - Institut de l'Information Scientifique et Technique

    Cote : 98-0295828

    Code Inist : 002B07. Création : 27/11/1998.